Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Reg Anesth Pain Med. 2012 Nov;37(6):601–606. doi: 10.1097/AAP.0b013e3182664afb

Table 1. Survival in response to lidocaine after acute or chronic hyperglycemia.

Treatment group Survival n Significance
Acute hyperglycemia (24 hours)

1. Control 105 ± 4 9 S vs. 2 and 4
NS vs. 3
2. Lidocaine 45 ±15 17 S vs. 1 and 3
NS vs. 4
3. High glucose 107 ± 6 17 S vs. 2 and 4
NS vs. 1
4. High glucose plus lidocaine 55 ±13 17 S vs. 1 and 3
NS vs. 2
Chronic hyperglycemia (72 hours)

1. Control 103 ± 4 9 S vs. 2 and 4
NS vs. 3
2. Lidocaine (as above) 45 ± 15 17 S vs. 1 and 3
NS vs. 4
3. High glucose 102 ±7 17 S vs. 2 and 4
NS vs. 1
4. High glucose plus lidocaine 53 ± 27 16 S vs. 1 and 3
NS vs. 2

Legend: S significant NS non-significant.

HHS Vulnerability Disclosure